Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Savarese Cardioconsultancy AB
AB
Active
Org 5592770209
Torsplan 8
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2020
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 1,2M
+19% vs 2023
EBITDA margin
72.2%
+46% vs 2023
Equity ratio
46.0%
Financial strength
Net profit 2024
SEK 501K
+29% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
0M
2021
1M
+100%
2022
1M
0%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 1,2M
+19%
EBITDA
SEK 862K
+46%
Net profit
SEK 501K
+29%
Total assets
SEK 1,1M
+29%
Equity
SEK 526K
+22%
Employees
0
—
Company information
Legal name
Savarese Cardioconsultancy AB
Org number
5592770209
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
15 oktober 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Verksamheten kommer att erbjuda konsultationer och forskningar inom kardiovaskulärvetenskap.
Contact
Address
Torsplan 8
Email
gianluigi.savarese@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
1M
2023
1M
2024
Income statement
SEK thousands
Item
2021
2022
2023
2024
Revenue
238
820
1 003
1 194
Staff expenses
—
—
—
−2
EBITDA
161
666
591
862
Depreciation & amort.
−0
—
—
—
EBIT
161
666
591
862
Net financials
—
−1
0
−1
Profit before tax
160
499
492
638
Tax
−34
−103
−103
−137
Net profit
126
396
389
501
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
Total assets
187
720
890
1 144
Equity
151
421
430
526
Long-term debt
0
—
—
—
Short-term debt
35
133
194
130
Total debt
35
133
194
130
Financial ratios
5-year trend
EBITDA margin
72.2%
This company
15.8%
Market median
+357% vs market
2021
2024
Equity ratio
46.0%
This company
38.2%
Market median
+20% vs market
2021
2024
Return on equity
95.2%
This company
18.4%
Market median
+417% vs market
2021
2024
Net profit margin
42.0%
This company
8.1%
Market median
+419% vs market
2021
2024
Asset turnover
1.04×
This company
1.12×
Market median
+7% vs market
2021
2024
Debt / equity
1.17×
This company
0.62×
Market median
-89% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
GS
Gianluigi Savarese
Board of Directors
2022
AV
Alessandro Volpicella
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Savarese Cardioconsultancy AB also hold positions in
0
other companies.
Person
Role here
Other companies
Gianluigi Savarese
Board of Directors
0 companies
Alessandro Volpicella
Deputy Board Member
0 companies